Purecore Metals Inc.CSE: PURE

Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences

· Issued by Purecore Metals Inc. via ACCESS Newswire

NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Saleen Automotive Inc. (OTC: SLNN), Cherubim Interests Inc. (OTC: CHIT), Fission Uranium Corp. (OTC: FCUUF) and Pure Biosciences Inc. (OTC: PURE). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

To access our full PDF Research Packages for free, please visit the links below.

============

Full PDF DOWNLOAD Links

(You may have to copy and paste the links into your browser)

SLNN Research Package: http://www.traders-choice.com/pdf?s=SLNN

CHIT Research Package: http://www.traders-choice.com/pdf?s=CHIT

FCUUF Research Package: http://www.traders-choice.com/pdf?s=FCUUF

PURE Research Package: http://www.traders-choice.com/pdf?s=PURE

============

Highlights from today's reports include:

On Friday, January 29, 2016, NASDAQ Composite ended at 4,613.95 up 2.38%, Dow Jones Industrial Average advanced 2.47%, to finish the day at 16,466.30, and the S&P 500 closed at 1,940.24, up 2.48%.

- Saleen Automotive Inc.'s stock ended Friday's session flat at USD 0.0003. The company's shares oscillated between USD 0.0002 and USD 0.0004, marking a new 52-week low during the session. The stock recorded a trading volume of 33.98 million shares, much below its 50-day daily average volume of 67.20 million shares but above its 52-week average volume of 21.90 million shares. Over the last three days Saleen Automotive Inc.'s shares have declined by 14.29% while in the past one week the stock has remained flat. Furthermore, over the last three months the stock has lost 62.50% and in the past six months the shares have shed 57.14%. The stock is trading at a price to sales ratio of 0.04. In addition, the stock is trading below its 50-day and 200-day moving averages of USD 0.01 and USD 0.02, respectively.

- The stock of Cherubim Interests Inc. ended flat to close Friday's session at USD 0.0001. A trading volume of 1.10 million shares was recorded, much lower than its 150-day daily average volume of 35.41 million shares and its 52-week average volume of 31.06 million shares. Over the last five days Cherubim Interests Inc.'s shares have remained flat whereas in the past one month the stock has lost 66.67%. Additionally, over the last three months the stock has declined 93.75% and in the past six months the shares have registered a loss of 99.87%. Besides, the stock is trading below its 200-day moving average of USD 0.02. Cherubim Interests Inc.'s stock has a beta of 4.98.

- Fission Uranium Corp.'s stock increased by 5.20% to close Friday's session at USD 0.51. The company’s shares fluctuated in the range of USD 0.49 and USD 0.52. A total of 0.29 million shares exchanged hands, which was lower than its 50-day daily average volume of 0.89 million shares but above its 52-week average volume of 0.24 million shares. Over the last three days Fission Uranium Corp.'s shares have advanced 7.99% and in the past one week the stock has moved up 11.95%. Furthermore, over the last three months the stock has gained 21.67% while in the past six months the shares have shed 10.98%. The stock is trading at a price to book ratio of 1.00. In addition, the stock is trading above its 50-day moving average of USD 0.49 but below its 200-day moving average of USD 0.52.

- Pure Biosciences Inc.'s stock slipped by 1.64% to close Friday's session at USD 1.20. The company's shares oscillated between USD 1.15 and USD 1.22. The stock recorded a trading volume of 0.07 million shares, which was below its 50-day daily average volume of 0.13 million shares but above its 52-week average volume of 0.05 million shares. Over the last five days Pure Biosciences Inc.'s shares have declined by 5.51% while in the past one month the stock has gained a momentum of 27.48%. In addition, over the last three months the stock has gained 59.98% and in the past six months the shares have picked up 25.00%. The company has returned 71.43% in the past one year, on a compounded total return basis. The stock is trading at a price to book ratio of 12.43, compared to its historical PB ratio of 10.98. Additionally, the stock is trading at a price to sales ratio of 15.03.

--

About Trader's Choice:

Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TC has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.

NO WARRANTY

TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.

RESTRICTIONS

TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press (at) traders-choice.com

SOURCE: Trader's Choice

Company analysis